dc.contributor.author |
Vincent, Jean-Louis |
|
dc.contributor.author |
Privalle, Christopher |
|
dc.contributor.author |
Singer, Mervyn |
|
dc.contributor.author |
Lorente Balanza, José Ángel |
|
dc.contributor.author |
Boehm, Erwin |
|
dc.contributor.author |
Meier-Hellmann, Andreas |
|
dc.contributor.author |
Darius, Harald |
|
dc.contributor.author |
Ferrer, Ricard |
|
dc.contributor.author |
Sirvent, Josep Maria |
|
dc.contributor.author |
Marx, Gernot |
|
dc.contributor.author |
DeAngelo, Joseph |
|
dc.date.accessioned |
2015-07-18T17:20:18Z |
|
dc.date.available |
2015-07-18T17:20:18Z |
|
dc.date.issued |
2015 |
|
dc.identifier.citation |
Vincent, J. L., Privalle, C. T., Singer, M., Lorente, J. A., Boehm, E., Meier-Hellmann, A., ... & DeAngelo, J. (2015). Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*. Critical Care Medicine, 43(1), 57-64. |
spa |
dc.identifier.issn |
00903493 |
|
dc.identifier.issn |
15300293 |
|
dc.identifier.uri |
http://hdl.handle.net/11268/4216 |
|
dc.description.abstract |
The objective of this study is to compare the effectiveness and safety of the hemoglobin-based nitric oxide scavenger, pyridoxalated hemoglobin polyoxyethylene, against placebo in patients with vasopressor-dependent distributive shock. |
spa |
dc.language.iso |
spa |
spa |
dc.subject.other |
Vasodepresores |
spa |
dc.subject.other |
Hemoglobina |
spa |
dc.title |
Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)* |
spa |
dc.type |
article |
spa |
dc.description.impact |
7.422 JCR (2015) Q1, 4/33 Critical care medicine |
spa |
dc.identifier.doi |
10.1097/CCM.0000000000000554 |
|
dc.rights.accessRights |
closedAccess |
spa |
dc.subject.uem |
Sistema cardiovascular |
spa |
dc.subject.unesco |
Enfermedad cardiovascular |
spa |
dc.description.filiation |
UEM |
spa |
dc.peerreviewed |
Si |
spa |